Immune Checkpoint Inhibitor Therapy for Prostate Cancer: Present and Future Prospectives
Biomolecules · 22.05.2025 · 15 (6) · 751
DOI: 10.3390/biom15060751 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 22.05.2025. Verfasst von Vikrant Rai. Beteiligte Einrichtung: Department of Translational Research, Western University of Health Sciences, Pomona, CA 91762, USA. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Prostatic Neoplasms, Immunotherapy, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Prostate cancer, a slow-growing tumor, develops through the over-proliferation of malignant cells in the prostate and is one of the most common types of cancer. Active surveillance, radical prostatectomy, external beam radiation, brachytherapy, cryotherapy, stereotactic body radiation therapy, hormone therapy, and chemotherapy are common treatment strategies for prostate cancer. However, resistance to treatment in advanced prostate cancer is a concerning issue in the use of these therapies. Immune checkpoint inhibitor (ICI) therapy for prostate cancer is an emerging strategy for the treatment of advanced prostate cancers but the resistance and limited efficacy to ICIs observed in metastatic castration-resistant prostate cancer (mCRPC) raises concerns. The ongoing clinical trials for combination therapies for mCRPC have provided some hope. This review concisely discusses the molecular and cellular mechanisms, immunotherapy, the limitations of ICIs, combination therapies, and the prospects of developing novel therapeutics for prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Research, Western University of Health Sciences, Pomona, CA 91762, USA.
ORCID-Profile: Vikrant Rai
Zitieren
APA
Rai, V. (2025). Immune Checkpoint Inhibitor Therapy for Prostate Cancer: Present and Future Prospectives. Biomolecules, 15(6), 751. https://doi.org/10.3390/biom15060751
Vancouver
Rai V. Immune Checkpoint Inhibitor Therapy for Prostate Cancer: Present and Future Prospectives. Biomolecules. 2025;15(6):751. doi:10.3390/biom15060751
BibTeX
@article{Rai2025,
author = {Rai, Vikrant},
title = {Immune Checkpoint Inhibitor Therapy for Prostate Cancer: Present and Future Prospectives},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {6},
pages = {751},
doi = {10.3390/biom15060751}
}
EUVIMED